These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 17384984

  • 1. Multistep mouse mammary tumorigenesis through pre-neoplasia to neoplasia and acquisition of metastatic potential.
    Tsubura A, Yoshizawa K, Uehara N, Yuri T, Matsuoka Y.
    Med Mol Morphol; 2007 Mar; 40(1):9-17. PubMed ID: 17384984
    [Abstract] [Full Text] [Related]

  • 2. Preneoplastic lesions in murine mammary cancer.
    Medina D.
    Cancer Res; 1976 Jul; 36(7 PT 2):2589-95. PubMed ID: 179706
    [Abstract] [Full Text] [Related]

  • 3. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H, Stephens LC, Kumar R.
    Clin Cancer Res; 2006 Mar 01; 12(5):1479-86. PubMed ID: 16533771
    [Abstract] [Full Text] [Related]

  • 4. Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens.
    Medina D.
    J Mammary Gland Biol Neoplasia; 2008 Sep 01; 13(3):271-7. PubMed ID: 18663563
    [Abstract] [Full Text] [Related]

  • 5. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
    Green A, Shilkaitis A, Christov K.
    Carcinogenesis; 1999 Aug 01; 20(8):1535-40. PubMed ID: 10426803
    [Abstract] [Full Text] [Related]

  • 6. Genetically engineered mouse models of mammary intraepithelial neoplasia.
    Cardiff RD, Moghanaki D, Jensen RA.
    J Mammary Gland Biol Neoplasia; 2000 Oct 01; 5(4):421-37. PubMed ID: 14973386
    [Abstract] [Full Text] [Related]

  • 7. Neoplastic transformation of mammary epithelial cells in rats is associated with decreased apoptotic cell death.
    Shilkaitis A, Green A, Steele V, Lubet R, Kelloff G, Christov K.
    Carcinogenesis; 2000 Feb 01; 21(2):227-33. PubMed ID: 10657962
    [Abstract] [Full Text] [Related]

  • 8. Mammary tumorigenesis in chemical carcinogen-treated mice. IV. Induction of mammary ductal hyperplasias.
    Medina D, Warner MR.
    J Natl Cancer Inst; 1976 Aug 01; 57(2):331-7. PubMed ID: 826649
    [Abstract] [Full Text] [Related]

  • 9. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H.
    Mod Pathol; 2002 Feb 01; 15(2):116-24. PubMed ID: 11850540
    [Abstract] [Full Text] [Related]

  • 10. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.
    Ferreira E, Gobbi H, Saraiva BS, Cassali GD.
    Vet Pathol; 2012 Mar 01; 49(2):322-9. PubMed ID: 21282668
    [Abstract] [Full Text] [Related]

  • 11. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
    Namba R, Young LJ, Abbey CK, Kim L, Damonte P, Borowsky AD, Qi J, Tepper CG, MacLeod CL, Cardiff RD, Gregg JP.
    Clin Cancer Res; 2006 Apr 15; 12(8):2613-21. PubMed ID: 16638874
    [Abstract] [Full Text] [Related]

  • 12. The preneoplastic phenotype in murine mammary tumorigenesis.
    Medina D.
    J Mammary Gland Biol Neoplasia; 2000 Oct 15; 5(4):393-407. PubMed ID: 14973384
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneity of mammary lesions represent molecular differences.
    Namba R, Maglione JE, Davis RR, Baron CA, Liu S, Carmack CE, Young LJ, Borowsky AD, Cardiff RD, Gregg JP.
    BMC Cancer; 2006 Dec 05; 6():275. PubMed ID: 17147824
    [Abstract] [Full Text] [Related]

  • 14. Biological and molecular characteristics of the premalignant mouse mammary gland.
    Medina D.
    Biochim Biophys Acta; 2002 Oct 02; 1603(1):1-9. PubMed ID: 12242106
    [Abstract] [Full Text] [Related]

  • 15. Development and characterization of mouse hyperplastic mammary outgrowth lines from BALB/cfC3H hyperplastic alveolar nodules.
    Ashley RL, Cardiff RD, Mitchell DJ, Faulkin LJ, Lund JK.
    Cancer Res; 1980 Nov 02; 40(11):4232-42. PubMed ID: 6258774
    [Abstract] [Full Text] [Related]

  • 16. Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice.
    Derksen PW, Braumuller TM, van der Burg E, Hornsveld M, Mesman E, Wesseling J, Krimpenfort P, Jonkers J.
    Dis Model Mech; 2011 May 02; 4(3):347-58. PubMed ID: 21282721
    [Abstract] [Full Text] [Related]

  • 17. Cell proliferation and apoptosis during mammary carcinogenesis in pituitary isografted mice.
    Christov KT, Guzman RC, Swanson SM, Thordarson G, Talamantes F, Nandi S.
    Carcinogenesis; 1996 Aug 02; 17(8):1741-6. PubMed ID: 8761435
    [Abstract] [Full Text] [Related]

  • 18. Transgenic Polyoma middle-T mice model premalignant mammary disease.
    Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, Cardiff RD, MacLeod CL.
    Cancer Res; 2001 Nov 15; 61(22):8298-305. PubMed ID: 11719463
    [Abstract] [Full Text] [Related]

  • 19. Biological and genetic properties of the p53 null preneoplastic mammary epithelium.
    Medina D, Kittrell FS, Shepard A, Stephens LC, Jiang C, Lu J, Allred DC, McCarthy M, Ullrich RL.
    FASEB J; 2002 Jun 15; 16(8):881-3. PubMed ID: 11967232
    [Abstract] [Full Text] [Related]

  • 20. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.
    Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.